[{"Assets_0_Q3_USD":"98196000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.54","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.75","EarningsPerShareBasic_3_Q3_USD":"2.01","EarningsPerShareDiluted_1_Q3_USD":"0.75","EarningsPerShareDiluted_3_Q3_USD":"2.0","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162000000000.0","MinorityInterest_0_Q3_USD":"63000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"9760000000.0","NetIncomeLoss_1_Q3_USD":"1606000000.0","NetIncomeLoss_3_Q3_USD":"4305000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_3_Q3_USD":"3489000000.0","ProfitLoss_1_Q3_USD":"1608000000.0","ProfitLoss_3_Q3_USD":"4320000000.0","RevenuesConverted_1_Q3_USD":"11218000000.0","RevenuesConverted_3_Q3_USD":"34753000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"32734000000.0","StockholdersEquity_0_Q3_USD":"32671000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"2148000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"2154000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"2133000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"2137000000.0","filed":"20221026","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"BRISTOL MYERS SQUIBB CO","period":"20220930","qtrs":"0","uom":"USD"}]